Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01622764
What this trial is testing

89Zr-RO5323441 PET Imaging in Glioblastoma

Who this might be right for
Glioblastoma
University Medical Center Groningen
Testing effectiveness (Phase 2)Looking for participantsNCT07145047
What this trial is testing

Clinical Study of Oncolytic Virus in Glioblastoma

Who this might be right for
Glioblastoma (GBM)
Mianyang Central Hospital 20
Not applicableStudy completedNCT01990248
What this trial is testing

An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 339
Early research (Phase 1)Looking for participantsNCT06326411
What this trial is testing

Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Who this might be right for
OncologyMEK MutationRAF Gene Mutation+6 more
Nested Therapeutics, Inc 230
Not applicableNot Yet RecruitingNCT06516471
What this trial is testing

The Evolution of Neuroendoscopy Guided by Head-mounted Mixed Reality Technique Navigation System in Neurosurgery

Who this might be right for
Pineal TumorBrainstem TumorSurgery
Shanghai Zhongshan Hospital 40
Not applicableLooking for participantsNCT04735198
What this trial is testing

Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.

Who this might be right for
Midgut Carcinoid TumorBiliary Stones
Hospital Universitari de Bellvitge 100
Testing effectiveness (Phase 2)Study completedNCT00004147
What this trial is testing

COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Early research (Phase 1)UnknownNCT00701987
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Who this might be right for
Melanoma
Advanced Life Sciences, Inc. 12
Early research (Phase 1)Active Not RecruitingNCT02311621
What this trial is testing

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Seattle Children's Hospital 65
Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT02013336
What this trial is testing

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Who this might be right for
Recurrent or Refractory Solid TumorsEwing SarcomaRhabdomyosarcoma+2 more
South Plains Oncology Consortium 30
Testing effectiveness (Phase 2)UnknownNCT04223999
What this trial is testing

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Who this might be right for
Recurrent Glioblastoma
Anders Rosendal Korshøj 70
Not applicableUnknownNCT00813787
What this trial is testing

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Who this might be right for
Glioma
AHS Cancer Control Alberta 20
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableUnknownNCT03362138
What this trial is testing

Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions

Who this might be right for
MelanomaPigmented Skin LesionDysplastic Nevi
Assuta Hospital Systems 80
Early research (Phase 1)Study completedNCT00005943
What this trial is testing

Gene Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Colorado, Denver
Early research (Phase 1)Study completedNCT01149343
What this trial is testing

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

Who this might be right for
Melanoma
GlaxoSmithKline 107
Next Page